Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Idorsia Pharmaceuticals Ltd - Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant
Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant
GlobeNewswire

Exclusive agreement with Jamjoom Pharma covers commercialization and distribution of QUVIVIQ™ (daridorexant) in Saudi Arabia and the Levant region Allschwil, Switzerland – July 27, 2026 Idorsia Ltd (SIX: IDIA) has entered into an…

futurism.com - Joe Wilkins - Man Accused of Horrific Crimes Caught Hiding as Pharma Executive
Man Accused of Horrific Crimes Caught Hiding as Pharma Executive
Futurism | Science and Technology News

Can't-miss innovations from the bleeding edge of science and tech For over two decades, a notorious fugitive accused of horrible crimes in Rhode Island hid out in one of the places you'd most expect — the corner office of a Big Pharma…

thehindubusinessline.com - Stocks to watch on Monday: NBCC, NTPC, Aurobindo Pharma, Waaree Energies, Cyient, Dodla Dairy and more
Stocks to watch on Monday: NBCC, NTPC, Aurobindo Pharma, Waaree Energies, Cyient, Dodla Dairy and more
BusinessLine

NBCC (India) Ltd has bagged project management consultancy work orders aggregating to approximately ₹108.85 crore (excluding GST). The contracts were secured in the ordinary course of business from domestic government agencies across…

marketbeat.com - Orbimed Advisors LLC Buys 10,000 Shares of Ascendis Pharma A/S $ASND
Orbimed Advisors LLC Buys 10,000 Shares of Ascendis Pharma A/S $ASND
MarketBeat

Orbimed Advisors LLC increased its stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 5.8% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 181,977 shares of the…

marketbeat.com - Troluce Capital Advisors LLC Invests $22.78 Million in Ascendis Pharma A/S $ASND
Troluce Capital Advisors LLC Invests $22.78 Million in Ascendis Pharma A/S $ASND
MarketBeat

Troluce Capital Advisors LLC acquired a new position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The fund acquired 99,600 shares of the biotechnology company's stock…

fastcompany.com - Patrick Sisson - This automation tech turns old tractors into self-driving farming machines
This automation tech turns old tractors into self-driving farming machines
Fast Company

Show me a farmer, said Mike Burdick, vice president of Sabanto, an autonomous tractor startup in Itasca, Illinois, and I'll show you someone who has a million things he or she just doesn't have time to do in the course of their workday. He'll also…

cnbc.com - Jim Cramer - Jim Cramer: Here's the tech stock to buy in a market losing patience with tech
Jim Cramer: Here's the tech stock to buy in a market losing patience with tech
CNBC

It's not the spend, it's the return. That's what Friday's technology stock plunge said. I think it just might be the most significant tech selloff in more than a year. We need to know — potentially — what we are facing. We need to…

yahoo.com - Adrian Volenik - I'm 28, Getting Out of the Military and 'Super Financially Illiterate.' How Do I Get Off the Ground?
I'm 28, Getting Out of the Military and 'Super Financially Illiterate.' How Do I Get Off the Ground?
Yahoo!

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Many people assume financial literacy is something you're supposed to pick up along the way. But for those who never learned how budgeting…

yahoo.com - Caroline Lubinsky - Woman, 31, Says Sister Guilt-Tripped Her Into Cosigning $15,000 In Medical Debt - Then Stopped Making Payments Six Months Later
Woman, 31, Says Sister Guilt-Tripped Her Into Cosigning $15,000 In Medical Debt - Then Stopped Making Payments Six Months Later
Yahoo!

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. A woman, 31, cosigned a $15,000 medical financing loan for her sister's fertility treatments after weeks of pressure and tears over family dinners.

sfchronicle.com - Richard Zitrin - The shocking parallel between the Facebook addiction trial and the Oxycontin scandal
The shocking parallel between the Facebook addiction trial and the Oxycontin scandal
San Francisco Chronicle

By now, almost everyone knows about the evils of Oxycontin, how its addictive properties, dangerously high dosages, and highly manipulative marketing from Purdue Pharma caused addiction not just to “Oxy” but to heroin and fentanyl.

thehindubusinessline.com - Stock market today: Gift Nifty signals positive open as softer crude lifts sentiment
Stock market today: Gift Nifty signals positive open as softer crude lifts sentiment
BusinessLine

Indian equities are poised for a positive start to the week as a global market rally and softer crude oil prices, triggered by another Iran-US truce, lift investor sentiment. Gift Nifty at 23,950, a marginal gain for Nifty at open. Asians stocks…

marketbeat.com - Sei Investments Co. Has $35.62 Million Position in Teva Pharmaceutical Industries Ltd. $TEVA
Sei Investments Co. Has $35.62 Million Position in Teva Pharmaceutical Industries Ltd. $TEVA
MarketBeat

Sei Investments Co. lifted its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 22.5% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 1,182,751 shares of the…

marketbeat.com - HC Wainwright Predicts argenex's Q3 Earnings (NASDAQ:ARGX)
HC Wainwright Predicts argenex's Q3 Earnings (NASDAQ:ARGX)
MarketBeat

2 Ways to Play the Big Pharma Patent Cliff argenex SE (NASDAQ:ARGX - Free Report) - Equities researchers at HC Wainwright increased their Q3 2026 EPS estimates for argenex in a research report issued on Friday, July 24th. HC Wainwright analyst D.

fool.com - Ben Gran - Jamie Dimon Says Stock Valuations Are Too High. But That Shouldn't Change How You Invest. Consider These 3 ETFs.
Jamie Dimon Says Stock Valuations Are Too High. But That Shouldn't Change How You Invest. Consider These 3 ETFs.
The Motley Fool

JPMorgan Chase (JPM +0.95%) CEO Jamie Dimon recently gave a provocative interview with a CNBC podcast. On Monday, Dimon effectively said that he wouldn't buy most stocks right now at today's high valuations. Even if Dimon is somewhat bearish on the…

marketbeat.com - Best Growth Stocks To Consider - July 26th
Best Growth Stocks To Consider - July 26th
MarketBeat

Prologis Q1 2026: Data Centers Steal the Show Prologis, Teledyne Technologies, Ascendis Pharma A/S, Pattern Group, Hamilton Lane, Digital Turbine, and Andersen Group are the seven Growth stocks to watch today, according to MarketBeat's stock…

Receive a Daily briefing on Pharma Industry News

Get Started